News

Cushman & Wakefield Expands Atlanta Office Team with New Additions

Cushman & Wakefield Expands Atlanta Office Team with New Additions

Strengthening the Atlanta Office Agency Leasing Team

Cushman & Wakefield has announced the addition of three notable professionals to its Atlanta Office Agency Leasing team. Welcoming Stephen Clifton and Zach Wooten as Executive Directors along with Payton Maxheimer as an Associate marks a significant enhancement to the firm's capabilities.

Expertise for Tailored Client Solutions

These three new members aim to enrich the firm's efforts in marketing and leasing office spaces across the metro area. The commitment is to represent landlords effectively, focusing on their needs and property potentials.

Tyler Courtney, Managing Principal at the Atlanta office, emphasized the importance of building a strong team in the current office market landscape. He expressed his excitement about the joining of Clifton, Wooten, and Maxheimer, highlighting their roles in expanding Cushman & Wakefield's industry-leading investor services.

Comprehensive Integration of Services

The trio will work in synergy with Cushman & Wakefield’s existing divisions—property management, capital markets, and project management. This collaborative approach is intended to provide clients with an all-encompassing suite of services that aligns with their specific strategies and operational goals.

Market Adaptability and Growth Potential

Strategically, this integration is set to position the agency for growth in emerging market opportunities. Samir Idris, Executive Managing Director within the Southeast Capital Markets team, praised how this new addition enhances the firm's ability to maintain seamless solutions and respond adeptly to clients' diverse needs throughout the investment lifecycle.

Previous Experience and Collaborative Achievements

Before this venture, the trio honed their skills together at Transwestern’s Atlanta office. There, they crafted and executed strategies designed to maximize property value and returns for a varied clientele, from local operators to institutional investors and REITs.

Cushman & Wakefield's Legacy in Atlanta

With a presence in Atlanta since 1977, Cushman & Wakefield has built a strong reputation and is consistently ranked among the city’s foremost brokerage firms. The firm has expanded to employ over 750 professionals, who contribute their expertise across a variety of integrated services.

A Forward-Thinking Approach

Clifton and Wooten expressed their enthusiasm about joining a firm that champions innovation and a client-centric culture. They believe that Cushman & Wakefield’s collaborative environment aligns with their focus on delivering valuable real estate solutions.

About Cushman & Wakefield

Cushman & Wakefield (NYSE: CWK) stands as a leading global commercial real estate services firm. With around 52,000 employees spanning nearly 400 offices in over 60 countries, their 2023 revenues reached $9.5 billion across various core services. The firm's commitment to creating a diverse and inclusive workplace, alongside its principles of sustainability, continues to earn numerous accolades in the industry.

Frequently Asked Questions

Why did Cushman & Wakefield add new members to its team?

The new additions aim to bolster the firm’s Office Agency Leasing capabilities and enhance client service in a competitive market.

What roles do the new team members hold?

Stephen Clifton and Zach Wooten join as Executive Directors, while Payton Maxheimer is welcomed as an Associate.

How does this affect Cushman & Wakefield’s service offerings?

The integration of this team will provide more comprehensive and tailored solutions for landlords and institutional clients.

Where did the new team members work before joining Cushman & Wakefield?

Prior to their current roles, they were part of the Agency Leasing team at Transwestern’s Atlanta office.

What is Cushman & Wakefield’s legacy in Atlanta?

Cushman & Wakefield has built a notable reputation in Atlanta since 1977, employing over 750 professionals and consistently ranking among the top in brokerage and property management firms.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles